Evaluation of Safety & Effectiveness of the Biomimics 3d Stent System (Mimics-2)
view all Clinical Trials
The BioMimics 3D stent is intended to improve luminal diameter in the treatment of symptomatic de-novo, obstructive or occlusive lesions in native femoropopliteal arteries with reference vessel diameters ranging from 4.0 - 6.0 mm. Subjects with symptomatic atherosclerotic disease of the femoropopliteal artery who comply with all study eligibility criteria may be considered for enrollment.
For more information about this trial or to inquire about eligibility, call 215-707-4740 or email email@example.com.